These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6765149)

  • 21. Islet-cell antibodies detection using porcine and human pancreas in type I insulin-dependent diabetes (IDD).
    Suriani R; Dall'Olmo AM; Bellone G; Castagneri R; Cavallo-Perin P; Donadio F; Pagano G
    Panminerva Med; 1988; 30(1):7-9. PubMed ID: 3047633
    [No Abstract]   [Full Text] [Related]  

  • 22. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type 1 and type 2 diabetes: clinical parallels].
    Boitard C
    Journ Annu Diabetol Hotel Dieu; 2004; ():1-10. PubMed ID: 15259300
    [No Abstract]   [Full Text] [Related]  

  • 24. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.
    Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF
    J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 diabetes mellitus.
    Larger E; Dubois-Laforgue D
    Ann Med Interne (Paris); 1999 Apr; 150(3):254-63. PubMed ID: 10445097
    [No Abstract]   [Full Text] [Related]  

  • 26. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I; Souchier C; Thivolet C
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HLA antigens in Chilean insulin-dependent diabetic patients].
    Uriarte M; Mella I; Jurlow E; Melendez M; Fuentes C; Wegmann ME; García de los Ríos M
    Rev Med Chil; 1987 Mar; 115(3):193-200. PubMed ID: 3481102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical heterogeneity of childhood diabetes in Baranya county].
    Makovi H; Soltész G; Hermann R
    Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological studies on insulin-dependent diabetes mellitus (IDDM). I. Natural killer (NK) cell activity].
    Tomoda T; Hamada F; Zushi N; Kurashige T; Kitamura I; Kunitomi T
    Arerugi; 1987 Mar; 36(3):162-8. PubMed ID: 3300607
    [No Abstract]   [Full Text] [Related]  

  • 32. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Type 1 or Type 2 diabetes: diagnostic aids in clinically uncertain cases].
    Spinas GA
    Schweiz Rundsch Med Prax; 1991 Dec; 80(49):1367-8. PubMed ID: 1745887
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors of importance for residual beta-cell function in type I diabetes mellitus. A review.
    Madsbad S
    Acta Med Scand Suppl; 1983; 671():61-7. PubMed ID: 6349267
    [No Abstract]   [Full Text] [Related]  

  • 35. The aetiology of diabetes.
    N Z Med J; 1976 Oct; 84(573):281-2. PubMed ID: 794779
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA-types, C-peptide and insulin antibodies in juvenile diabetics [proceedings].
    Ludvigsson J; Heding L; Säfwenberg J
    Diabete Metab; 1976 Sep; 2(3):158. PubMed ID: 1010130
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological features in the course of type 1 diabetes.
    Ilonen J; Mustonen A; Akerblom HK; Kouvalainen K
    Ann Clin Res; 1984; 16(2):64-73. PubMed ID: 6380389
    [No Abstract]   [Full Text] [Related]  

  • 38. [Etiology and development of insulin-dependent diabetes mellitus].
    Martynova MI
    Pediatriia; 1985 Jan; (1):43-7. PubMed ID: 3883309
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of allogeneic lymphocyte E-rosettes induced by sera from newly diagnosed type I diabetics.
    Pozzilli P; Di Mario U; Javicoli M; Menzinger G; Andreani D
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):49-53. PubMed ID: 6986737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HLA antigens and anti-insulin alloantibodies in type 1 diabetics].
    Blickle JF; Vetter D; Audhuy B; Tongio M; Hauptmann G; Brogard JM; Mayer S
    Ann Med Interne (Paris); 1988; 139(2):142-3. PubMed ID: 3395063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.